TURNOVER (x1000 EUR)
NET PROFIT (x1000 EUR)
EMPLOYEES
Biogen Norway AS
Closing information (x1000 EUR)
Closing information | 2023/12 | 2022/12 | 2021/12 |
Turnover |
22,590
|
27,016
|
38,645 |
Financial expenses |
1
|
22
|
39 |
Earnings before taxes |
1,085
|
909
|
1,763 |
Total assets |
18,749
|
18,848
|
21,714 |
Current assets |
18,733
|
18,823
|
21,679 |
Current liabilities |
3,344
|
3,300
|
6,051 |
Equity capital |
15,404
|
15,548
|
15,663 |
- share capital |
9
![]() |
9
|
10 |
Employees (average) |
26
|
19 |
Financial ratios
Fiscal year | 2023/12 | 2022/12 | 2021/12 |
Solvency |
82.2%
|
82.5%
|
72.1% |
Turnover per employee |
1,039
|
2,034 | |
Profit as a percentage of turnover |
4.8%
|
3.4%
|
4.6% |
Return on assets (ROA) |
5.8%
|
4.9%
|
8.3% |
Current ratio |
560.2%
|
570.4%
|
358.3% |
Return on equity (ROE) |
7.0%
|
5.8%
|
11.3% |
Change turnover |
-2,710
|
-9,599
|
-8,824 |
Change turnover % |
-11%
|
-26%
|
-19% |
Chg. No. of employees |
7
|
2 | |
Chg. No. of employees % |
37%
|
12% |
Total value of public sale
Fiscal year | 2023/12 | 2022/12 | 2021/12 |
Total value of public sale |
0
![]() |
0
![]() |
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.